Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Levetiracetam
Keppra
Routinely available
SMC (311/06)
09/11/2023
Indication
Epilepsy
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
500mg/5ml concentrate for infusion
Comments
-
Link to Advice
Advice Published
09/10/2006
SMC Submission Type
Abbreviated
SMC Status
Accepted